The UBS 2016 Global Healthcare Conference
Logotype for CVS Health Corporation

CVS Health (CVS) The UBS 2016 Global Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for CVS Health Corporation

The UBS 2016 Global Healthcare Conference summary

4 Nov, 2026

Integrated strategy and market positioning

  • Strategy centered on addressing the cost-quality-access challenge through integrated assets intended to improve outcomes and lower costs for patients, payers, and providers.

  • Channel-agnostic programs, specialty capabilities, purchasing scale, retail clinics, and long-term care services positioned as differentiated offerings for healthcare partners.

  • Caremark managed claims grew more than 57% since 2008, while enterprise dispensing volume rose more than 70% over the same period.

  • Enterprise dispensing share of Caremark business increased 700 bps since 2008, adding $7B in dispensed revenue, including $2B in 2015.

PBM performance and client wins

  • 2016 PBM gross new business wins reached $15.2B; client retention was 97.3%, producing $13.1B of net new business.

  • 2016 wins included $1.8B from 91 new employer clients; about 83% of gross wins came from health plans, including Aetna Coventry Medicare Part D lives.

  • Client prescription drug trend fell from 11.8% in 2014 to 5% in 2015; proactive cost management cut trend by more than 50% despite record drug price increases.

  • 2017 selling season was off to a good start despite CalPERS and ERS contract losses; a quantitative update was planned for a later earnings call.

  • 2015 enterprise dispensing exceeded 1.3B prescriptions and Caremark managed more than 1.1B claims, supporting procurement scale and manufacturer negotiations.

Specialty, retail, and clinic growth

  • Specialty market projected to exceed $200B by 2020; specialty revenue was more than $40B in 2015 and projected at ~$49B in 2016.

  • CVS Specialty dispensed revenue grew at more than 32% CAGR from 2012 to 2016, versus 19% industry CAGR; offerings included Specialty Connect and rare-disease nursing support.

  • Retail pharmacy growth was twice the overall retail market; nearly 44% of retail growth over the prior two years came from share gains with other payers.

  • Medication possession ratios for three chronic conditions were ~650 bps above the top three retail competitors; Target acquisition added more than 1,600 pharmacies and 80 clinics.

  • Target locations were expected to convert to CVS Pharmacy and MinuteClinic brands by end of summer 2016; MinuteClinic operated more than 1,100 clinics across 33 states and Washington, D.C.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from CVS Health